Research map: AS1411-functionalized albumin nanoparticles for nucleolin-targeted realgar delivery and therapy in triple-negative breast cancer

Back to the article

Papers in this map

  1. mTOR Signaling in Growth, Metabolism, and Disease · Robert A. Saxton · 2017 · 7778 citations · Cited by this paper
  2. Tislelizumab combined with Anti-GD2 antibody-based chemoimmunotherapy for pediatric relapsed/refractory high-risk neuroblastoma: a two-Case Report · 2026 · Related
  3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease · Giampaolo Bianchini · 2016 · 3204 citations · Cited by this paper
  4. Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development · 2026 · Related
  5. Aptamers as targeted therapeutics: current potential and challenges · Jiehua Zhou · 2016 · 2248 citations · Cited by this paper
  6. A nomogram based on LASSO-logistic regression for predicting tocilizumab-associated hypofibrinogenemia in patients with rheumatic diseases · 2026 · Related
  7. Albumin-based nanoparticles as potential controlled release drug delivery systems · Ahmed O. Elzoghby · 2011 · 1528 citations · Cited by this paper
  8. Traditional Chinese medicine interventions targeting Wnt/β-catenin signaling in cerebral ischemia/reperfusion injury: a review · 2026 · Related
  9. Triple negative breast cancer: Pitfalls and progress · Paola Zagami · 2022 · 848 citations · Cited by this paper
  10. NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution · 2026 · Related
  11. Arsenic-induced oxidative stress and its reversibility · Swaran J.S. Flora · 2011 · 831 citations · Cited by this paper
  12. Endothelial EPAS1 as a prognostic and therapeutic target in acute myocardial infarction: integrative bioinformatics, Mendelian randomization and experimental validation · 2026 · Related
  13. Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemia · Lan Wang · 2008 · 739 citations · Cited by this paper
  14. Hematopoietic and T-lymphopoiesis-stimulating effects of a fluorinated pyrazolopiperidine β-cyclodextrin complex in cyclophosphamide-induced hematopoietic suppression · 2026 · Related
  15. Transport and interactions of nanoparticles in the kidneys · Bujie Du · 2018 · 660 citations · Cited by this paper
  16. Ganhai Weikang Capsules ameliorate functional dyspepsia in rats by modulating gut microbiota and host metabolic homeostasis · 2026 · Related
  17. Triple-negative breast cancer: epidemiological considerations and recommendations · Peter A. Boyle · 2012 · 600 citations · Cited by this paper
  18. Therapeutic potential of traditional Chinese medicine for hyperuricemia: mechanistic insights and clinical prospects · 2026 · Related
  19. Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results · Sergey K. Filippov · 2023 · 560 citations · Cited by this paper
  20. Tumor Cell-Targeting and Tumor Microenvironment–Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic/Photothermal/Chemodynamic Treatment of Cervical Cancer · Ying Wang · 2024 · 516 citations · Cited by this paper
  21. Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: A natural cargo · Gulam Rabbani · 2018 · 512 citations · Cited by this paper
  22. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer · Yunbo Nie · 2020 · 466 citations · Cited by this paper
  23. A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism · Elsa M. Reyes‐Reyes · 2010 · 388 citations · Cited by this paper
  24. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells · Sridharan Soundararajan · 2009 · 243 citations · Cited by this paper
  25. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review · Raghu Solanki · 2021 · 196 citations · Cited by this paper
  26. Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy · Liping Dong · 2023 · 165 citations · Cited by this paper
  27. Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation · Zhoujiang Chen · 2023 · 145 citations · Cited by this paper
  28. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments · Tao Sun · 2023 · 134 citations · Cited by this paper
  29. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination · Nuno André Fonseca · 2015 · 123 citations · Cited by this paper
  30. Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug Release · Haimei Chen · 2006 · 119 citations · Cited by this paper
  31. Balance Cell Apoptosis and Pyroptosis of Caspase-3-Activating Chemotherapy for Better Antitumor Therapy · Lingjiao Li · 2022 · 117 citations · Cited by this paper
  32. The medicinal use of realgar (As4S4) and its recent development as an anticancer agent · Jinzhu Wu · 2011 · 112 citations · Cited by this paper
  33. Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy · Haimeng Yuan · 2025 · 111 citations · Cited by this paper
  34. Anti-nucleolin aptamer AS1411: an advancing therapeutic · Alexander Van den Avont · 2023 · 109 citations · Cited by this paper
  35. In vitro hemocompatibility testing of medical devices · Martina Nalezinková · 2020 · 107 citations · Cited by this paper
  36. Nanomedicine: controlling nanoparticle clearance for translational success · Geyunjian Harry Zhu · 2022 · 101 citations · Cited by this paper
  37. As 4 S 4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia · Jian-Hua Mao · 2010 · 88 citations · Cited by this paper
  38. Targeting nano-regulator based on metal–organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer · Shu Wei Huang · 2023 · 78 citations · Cited by this paper
  39. Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis · Shengmei Wang · 2025 · 62 citations · Cited by this paper

Source: OpenAlex (CC0)